+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

High Content Screening/Imaging: Technologies and Global Markets 2021-2026

  • ID: 5412047
  • Report
  • August 2021
  • Region: Global
  • 219 Pages
  • BCC Research
UP TO OFF until May 31st 2022

FEATURED COMPANIES

  • Aurelia Bioscience Ltd.
  • Charles River
  • Cytoo Sa
  • Fluxion Biosciences
  • Logos Biosystems
  • Perkinelmer Inc.

The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.






The North American market for high content screening/imaging technology should grow from $448.2 million in 2021 to $744.1 million by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.The 


European market for high content screening/imaging technology should grow from $336.8 million in 2021 to $674.5 million by 2026 with a compound annual growth rate (CAGR) of 14.9% for the period of 2021-2026


Report Scope

The current report offers a detailed picture of the high content screening/imaging market.


This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2026, as well as key market players.


This report discusses the high content screening/imaging industry and its various resources. It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, providing an analysis of drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies and neuroscience. A complete regional analysis of the market is also studied in the report.


Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.


The Report Includes

  • 44 data tables and 28 additional tables
  • An overview of the global markets and technologies for high content screening/imaging
  • Estimation of the market size and analyses of market trends, with data from 2019, 2020, estimates for 2021 and projection of CAGR through 2026
  • Quantification of high content screening/imaging market based on component, end user, application, and region, and analysis of market drivers, restraints and other forces impacting the global market
  • Highlights of the current and future market potential, detailed analysis of the regulatory framework and policies and information on new technologies and innovations of the industry
  • Discussion on advantages of high-throughput screening over manual screening, and COVID-19 impact on MedTech and medical tourism
  • Coverage of recent developments, research and development (R&D) exploration, clinical trials and government programs to predict market trends of the HCS/I market
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players, including Molecular Devices (Danaher), Thermo Fisher Scientific, Becton, Dickinson and Co., PerkinElmer Inc., Genedata AG, and Yokogawa Electric Corp.
Frequently Asked Questions about the Global High Content Screening/Imaging: Technologies Market

What is the estimated value of the Global High Content Screening/Imaging: Technologies Market?

The Global High Content Screening/Imaging: Technologies Market was estimated to be valued at $1.2 Billion in 2021.

What is the growth rate of the Global High Content Screening/Imaging: Technologies Market?

The growth rate of the Global High Content Screening/Imaging: Technologies Market is 13.5%, with an estimated value of $2.3 Billion by 2026.

What is the forecasted size of the Global High Content Screening/Imaging: Technologies Market?

The Global High Content Screening/Imaging: Technologies Market is estimated to be worth $2.3 Billion by 2026.

Who are the key companies in the Global High Content Screening/Imaging: Technologies Market?

Key companies in the Global High Content Screening/Imaging: Technologies Market include Albany Molecular Research Inc. (Amri), Aurelia Bioscience Ltd., Axxam Spa, Becton, Dickinson And Co., BioTek (Agilent), Charles River, Corning Inc., Creative Biolabs and Cytoo Sa.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurelia Bioscience Ltd.
  • Charles River
  • Cytoo Sa
  • Fluxion Biosciences
  • Logos Biosystems
  • Perkinelmer Inc.

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in this Report?
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports


Chapter 2 Summary and Highlights
  • Overview


Chapter 3 Market and Technology Background
  • Overview
  • Scanning Probe Microscopy
  • Scanning Electron Microscopy
  • Transmission Electron Microscopy
  • Technological Advancements
  • Cytometers
  • Detectors/Sensors
  • Liquid Handling Instruments
  • Process Overview
  • High Content Screening (HCS)
  • High Throughput Screening (HTS)


Chapter 4 Impact of COVID-19 Pandemic
  • Introduction
  • Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism


Chapter 5 Market Dynamics
  • Market Drivers
  • Increasing R&D Budget
  • Advantages Over Manual and High-Throughput Screening
  • Technological Advancements in High Content Screening/Imaging
  • Market Restraints
  • Expensive Equipment
  • Inadequate Infrastructure and Funding for R&D in Emerging Countries
  • Market Opportunities
  • Opportunities in Various 3D Applications
  • Emerging Economies


Chapter 6 Market Breakdown by Component
  • Instruments and Platforms
  • Imaging Devices
  • Cytometers
  • Plate Readers
  • Light Sources
  • Detectors/Sensors
  • Liquid Handling Instruments
  • Market Size and Forecast
  • Consumables (Reagents and Kits)
  • Market Size and Forecast
  • Software and Analytics
  • Store Image and Database Management Software by Thermo Fisher Scientific
  • OpenHiCAMM (Open Hi Content Acquisition for µManager) Software
  • Market Size and Forecast
  • Services
  • siRNA Screens
  • Analysis of Fluorescent Cellular Assay
  • Robotic Liquid and Microplate Handling
  • Market Size and Forecast


Chapter 7 Market Breakdown by Application
  • Global Market for High Content Screening/Imaging by Application
  • Drug Discovery
  • Oncology
  • Compound Profiling
  • Molecular Diagnosis
  • Toxicity Studies
  • Neuroscience


Chapter 8 Market Breakdown by End User
  • Global Market for High Content Screening/Imaging by End User
  • Companies
  • Academics
  • Laboratories and Pathology Centers


Chapter 9 Market Breakdown by Region
  • Global Market for High Content Screening/Imaging by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


Chapter 10 Patent Review
  • Introduction
  • Patents Issued by Publication Year, 2015-2017


Chapter 11 Competitive Landscape
  • Overview
  • Company Share Analysis
  • Strategies
  • Regional Distributors
  • End Users
  • Recent Developments


Chapter 12 Pricing Analysis of Instruments by Major Players
  • Thermo Fisher Scientific
  • Molecular Devices (Danaher)
  • Yokogawa Electric Corp.
  • BioTek (Agilent)
  • Essen Bioscience (Sartorius)
  • Logos Biosystems
  • Other Major Players


Chapter 13 Company Profiles
  • Albany Molecular Research Inc. (Amri)
  • Aurelia Bioscience Ltd.
  • Axxam Spa
  • Becton, Dickinson And Co.
  • Biotek Instruments Inc.
  • Charles River
  • Corning Inc.
  • Creative Biolabs
  • Curiox Biosystems Inc.
  • Cytoo Sa
  • Danaher Corp.
  • De Novo Software
  • Discoverx Corp.
  • Essen Bioscience
  • Fluxion Biosciences
  • Genedata Ag
  • Hudson Robotics Inc.
  • Instrument Systems
  • Lumencor Inc.
  • Merck Millipore
  • Olympus Corp.
  • Perkinelmer Inc.
  • Phenovista Biosciences Llc
  • Platypus Technologies
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Thorlabs Inc.
  • Vala Sciences Inc.
  • Yokogawa Electric Corp.


List of Tables
Summary Table: Global Market for High Content Screening/Imaging Technology, by Region, Through 2026
Table 1: Microscopes Used in High Content Screening/Imaging
Table 2: HTS Detection Methods
Table 3: Comparison of Cellomics with Other Omics Techniques
Table 4: Global Market for High Content Screening/Imaging, by Component, Through 2026
Table 5: Global Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 6: High Content Screening/Imaging Platforms, by Thermo Fisher Scientific
Table 7: Cytometers
Table 8: Microplate Readers Available in the Market and Their Manufacturers
Table 9: Fluorescent Dyes Used for the Sensor Array
Table 10: Automated Liquid Handling Modules
Table 11: Global Market for High Content Screening/Imaging Instruments and Platforms, by Region, Through 2026
Table 12: Specification of HCS Live/Dead Green Kit
Table 13: Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), by Region, Through 2026
Table 14: Global Market for High Content Screening/Imaging Software and Analytics, by Region, Through 2026
Table 15: Global Market for High Content Screening/Imaging Services, by Region, Through 2026
Table 16: Global Market for High Content Screening/Imaging, by Application, Through 2026
Table 17: Global Market for High Content Screening/Imaging in Drug Discovery Applications, by Region, Through 2026
Table 18: Global Market for High Content Screening/Imaging in Oncology Applications, by Region, Through 2026
Table 19: Global Market for High Content Screening/Imaging in Compound Profiling Applications, by Region, Through 2026
Table 20: Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, by Region, Through 2026
Table 21: Global Market for High Content Screening/Imaging in Toxicity Studies, by Region, Through 2026
Table 22: Global Market for High Content Screening/Imaging in Neuroscience Applications, by Region, Through 2026
Table 23: Global Market for High Content Screening/Imaging, by End User, Through 2026
Table 24: Global Market for High Content Screening/Imaging for Company End Users, by Region, Through 2026
Table 25: Institutes with High Content Screening/Imaging Facilities
Table 26: Global Market for High Content Screening/Imaging for Academic End Users, by Region, Through 2026
Table 27: Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, by Region, Through 2026
Table 28: Global Market for High Content Screening/Imaging, by Region, Through 2026
Table 29: North American Market for High Content Screening/Imaging, by Component, Through 2026
Table 30: North American Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 31: North American Market for High Content Screening/Imaging, by Application, Through 2026
Table 32: North American Market for High Content Screening/Imaging, by End User, Through 2026
Table 33: North American Market for High Content Screening/Imaging, by Country, Through 2026
Table 34: Estimated Number of New Cancer Cases in the U.S., by Cancer Site, 2021
Table 35: European Market for High Content Screening/Imaging, by Component, Through 2026
Table 36: European Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 37: European Market for High Content Screening/Imaging, by Application, Through 2026
Table 38: European Market for High Content Screening/Imaging, by End User, Through 2026
Table 39: European Market for High Content Screening/Imaging, by Country, Through 2026
Table 40: Asia-Pacific Market for High Content Screening/Imaging, by Component, Through 2026
Table 41: Asia-Pacific Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 42: Asia-Pacific Market for High Content Screening/Imaging, by Application, Through 2026
Table 43: Asia-Pacific Market for High Content Screening/Imaging, by End User, Through 2026
Table 44: Japanese Market Statistics
Table 45: Vaccine Manufacturers in India
Table 46: Rest of the World Market for High Content Screening/Imaging, by Component, Through 2026
Table 47: Rest of the World Market for High Content Screening/Imaging, by Segment, Through 2026
Table 48: Rest of the World Market for High Content Screening/Imaging, by Application, Through 2026
Table 49: Rest of the World Market for High Content Screening/Imaging, by End User, Through 2026
Table 50: Number of Patents Issued for High content Screening/Imaging Technology, by Key Company/Assignee
Table 51: Number of Patents Issued for High Content Screening/Imaging Technology, by Category, 2015-2017
Table 52: Number of Patents Issued for High Content Screening/Imaging Technology, by Assignee’s Country, 2015-2017
Table 53: Number of Patents Issued for High Content Screening/Imaging Technology, by Publication Year, 2015-2017
Table 54: Patents Issued for High Content Screening/Imaging Technology, January 2015–December 2017
Table 55: Thermo Fisher Scientific Products Covered, by One or More Patents
Table 56: Patents on Molecular Devices Patents, 2015-2017
Table 57: Recent Developments in the High Content Screening/Imaging Technology Market, 2017-2021
Table 58: Average Selling Price of Products, Thermo Fisher Scientific
Table 59: Average Selling Price of Products, Molecular Devices
Table 60: Average Selling Price of Products, Yokogawa Electric Corp
Table 61: Average Selling Price of Products, BioTek (Agilent)
Table 62: Average Selling Price of Products, Essen Bioscience (Sartorius)
Table 63: Average Selling Price of Products, Logos Biosystems
Table 64: Average Selling Price of Products, Other Players
Table 65: BD: Product Portfolio
Table 66: BioTek Instruments: Product Portfolio
Table 67: Corning Inc.: Product Portfolio
Table 68: CYTOO SA: Product Portfolio
Table 69: Essen BioScience: Product Portfolio
Table 70: Olympus Corp.: Product Portfolio
Table 71: Thermo Fisher Scientific: Product Portfolio


List of Figures
Summary Figure A: Global Market for High Content Screening/Imaging Technology, by Region, 2019-2026
Summary Figure B: Global Market Shares of High Content Screening/Imaging Technology, by Region, 2020
Figure 1: Approaches for Imaging Sample Surfaces
Figure 2: HCS in Drug Discovery
Figure 3: Four Steps of Data Analysis
Figure 4: Basic Tools for High Content Screening
Figure 5: Advantages of HTS
Figure 6: Applications of High-Throughput Screening
Figure 7: Software Utilized for Data Analysis
Figure 8: Flow of Funding for Disease Research, 2014-2018
Figure 9: Share of Investments in Drug Discovery and Clinical Research, by Funding Category, 2018
Figure 10: Technological Advancements in High Content Screening
Figure 11: Global Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 12: Global Market for High Content Screening/Imaging, by Component, 2019-2026
Figure 13: Global Market Shares of High Content Screening/Imaging Instruments and Platforms, by Component, 2020
Figure 14: Key Benefits of Vectra Polaris Imaging Device
Figure 15: Five Main Components of a Flow Cytometer
Figure 16: Microplate Reader Categories
Figure 17: Global Market for High Content Screening/Imaging Instruments and Platforms, 2019-2026
Figure 18: Global Market for High Content Screening/Imaging Instruments and Platforms, by Region, 2019-2026
Figure 19: Features of Thiol Tracker Violet
Figure 20: Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), 2019-2026
Figure 21: Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), by Region, 2019-2026
Figure 22: Features of HCS Studio 2.0 Cell Analysis Software
Figure 23: Features of Store Image and Database Management Software
Figure 24: Key Features of OpenHiCAMM
Figure 25: OpenHiCAMM: High Content Screening/Imaging Software for Complex Microscope Imaging Workflows
Figure 26: Global Market for High Content Screening/Imaging Software and Analytics, 2019-2026
Figure 27: Global Market for High Content Screening/Imaging Software and Analytics, by Region, 2019-2026
Figure 28: Analysis of a Fluorescent Cellular Assay
Figure 29: Global Market for High Content Screening/Imaging Services, 2019-2026
Figure 30: Global Market for High Content Screening/Imaging Services, by Region, 2019-2026
Figure 31: Global Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 32: Drug Discovery Cycle
Figure 33: Features of the Lead Compound
Figure 34: Timeline of Drug Discovery and Development
Figure 35: Global Market for High Content Screening/Imaging in Drug Discovery Applications, 2019-2026
Figure 36: Global Market for High Content Screening/Imaging in Drug Discovery Applications, by Region, 2019-2026
Figure 37: Global Market for High Content Screening/Imaging in Oncology Applications, 2019-2026
Figure 38: Global Market for High Content Screening/Imaging in Oncology Applications, by Region, 2019-2026
Figure 39: Strategies to Improve Screening Using Compound Profiling
Figure 40: Global Market for High Content Screening/Imaging in Compound Profiling Applications, 2019-2026
Figure 41: Global Market for High Content Screening/Imaging in Compound Profiling Applications, by Region, 2019-2026
Figure 42: Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, 2019-2026
Figure 43: Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, by Region, 2019-2026
Figure 44: Types of Toxicity Studies
Figure 45: Global Market for High Content Screening/Imaging in Toxicity Studies, 2019-2026
Figure 46: Global Market for High Content Screening/Imaging in Toxicity Studies, by Region, 2019-2026
Figure 47: Global Market for High Content Screening/Imaging in Neuroscience Applications, 2019-2026
Figure 48: Global Market for High Content Screening/Imaging in Neuroscience Applications, by Region, 2019-2026
Figure 49: Global Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 50: Global Market for High Content Screening/Imaging for Company End Users, 2019-2026
Figure 51: Global Market for High Content Screening/Imaging for Company End Users, by Region, 2019-2026
Figure 52: Global Market for High Content Screening/Imaging for Academic End Users, 2019-2026
Figure 53: Global Market for High Content Screening/Imaging for Academic End Users, by Region, 2019-2026
Figure 54: Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, 2019-2026
Figure 55: Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, by Region, 2019-2026
Figure 56: Global Market for High Content Screening/Imaging, by Region, 2019-2026
Figure 57: Global Market Shares of High Content Screening/Imaging, by Region, 2020
Figure 58: North American Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 59: North American Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 60: North American Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 61: North American Market Shares of High Content Screening/Imaging, by Country, 2020
Figure 62: U.S. Market for High Content Screening/Imaging, 2019-2026
Figure 63: Number of New Cancer Cases in Canada, by Cancer Site, 2020
Figure 64: Canadian Market for High Content Screening/Imaging, 2019-2026
Figure 65: European Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 66: European Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 67: European Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 68: European Market Shares of High Content Screening/Imaging, by Country, 2020
Figure 69: German Market for High Content Screening/Imaging, 2019-2026
Figure 70: U.K. Market for High Content Screening/Imaging, 2019-2026
Figure 71: Share of New Cancer Cases in France, by Cancer Site, 2020
Figure 72: French Market for High Content Screening/Imaging, 2019-2026
Figure 73: Number of New Cancer Cases in Italy, by Cancer Site, 2020
Figure 74: Italian Market for High Content Screening/Imaging, 2019-2026
Figure 75: Share of New Cancer Cases in Spain, by Cancer Site, 2020
Figure 76: Spanish Market for High Content Screening/Imaging, 2019-2026
Figure 77: Rest of the European Market for High Content Screening/Imaging, 2019-2026
Figure 78: Asia-Pacific Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 79: Asia-Pacific Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 80: Asia-Pacific Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 81: Number of New Cancer Cases in China, by Cancer Site, 2020
Figure 82: Shares of New Cancer Cases in China, by Cancer Site, 2020
Figure 83: Chinese Market for High Content Screening/Imaging, 2019-2026
Figure 84: Japanese Market for High Content Screening/Imaging, 2019-2026
Figure 85: Indian Market for High Content Screening/Imaging, 2019-2026
Figure 86: Rest of Asia-Pacific Market for High Content Screening/Imaging, 2019-2026
Figure 87: Rest of the World Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 88: Rest of the World Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 89: Rest of the World Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 90: Rest of the World Market for High Content Screening/Imaging, 2019-2026
Figure 91: Global Market Shares of High Content Screening/Imaging Technology, by Manufacturer/Supplier, 2020
Figure 92: Strategies Adopted, by Key Market Players
Figure 93: BD: Annual Revenue, 2018–2020
Figure 94: BD: Revenue Share, by Geography, 2020
Figure 95: BD: Revenue Share, by Business Segment, 2020
Figure 96: BioTek Instruments (Agilent Technologies): Annual Revenue, 2018–2020
Figure 97: Charles River Laboratories: Annual Revenue, 2018–2020
Figure 98: Charles River Laboratories: Revenue Share, by Region, 2020
Figure 99: Corning Inc.: Annual Revenue, 2018–2020
Figure 100: Danaher Corp.: Annual Revenue, 2018-2020
Figure 101: Danaher Corp.: Revenue Share, by Geography, 2020
Figure 102: Danaher Corp.: Revenue Share, by Segment, 2020
Figure 103: Eurofins Pharma Discovery Services (Eurofins DiscoverX Products): Annual Revenue, 2018-2020
Figure 104: Merck KGaA: Annual Revenue, 2019-2020
Figure 105: Merck KGaA: Revenue Share, by Region, 2020
Figure 106: Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 107: Olympus Corp.: Annual Revenue, 2018-2020
Figure 108: PerkinElmer Inc.: Annual Revenue, 2017-2020
Figure 109: PerkinElmer Inc.: Revenue Share, by Region, 2020
Figure 110: PerkinElmer Inc.: Revenue Shares, by Business Unit, 2020
Figure 111: Tecan Trading AG: Annual Revenue, 2017-2020
Figure 112: Tecan Trading AG: Revenue Share, by Region, 2020
Figure 113: Tecan Trading AG: Revenue Shares, by Business Unit, 2020
Figure 114: Thermo Fisher Scientific: Annual Revenue, 2019-2020
Figure 115: Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 116: Thermo Fisher Scientific: Revenue Share, by Segment, 2020
Figure 117: Yokogawa Electric Corp.: Annual Revenue, 2018-2019
Figure 118: Yokogawa Electric Corp.: Revenue Share, by Business Unit, 2020
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Aurelia Bioscience Ltd.
  • Charles River
  • Cytoo Sa
  • Fluxion Biosciences
  • Logos Biosystems
  • Perkinelmer Inc.

The major factor contributing to the growth of the HCS/I market is the rising adoption of high content screening/imaging technology in research and development activities. The rapid adoption of HCS/Technology in the pharmaceutical industry and academic research centers indicates the importance of this information-rich screening tool. The imaging of cell function has become increasingly important to understand the underlying functional biology associated with new therapeutic targets. 


Demand for improved technologies for cell research, government support, and the emergence of sophisticated informatics solutions, along with rising demand for better screening systems, is augmenting the demand for high content imaging within fully automated screening laboratories. Furthermore, technological advancements and developments in biological research and the discovery of more effective therapies for the treatment of human disease are fueling the growth of the market. HCS/I systems have continually evolved with many improvements enabled to meet user demands of greater flexibility and the growing requirements of assays involving complex cellular disease models. Increasing drug discoveryR&D globally, increasing investments, and introduction of advanced imaging instruments are the other drivers for the HCS/I market. The high cost of HCS/I instrumentation is the primary factor restraining the growth of the market. 


The price of machinery and instrumentation prohibits a small economy country or a research organization from purchasing HCS/I equipment. Companies are introducing more sensitive cameras and better light sources, such as LED and multicolor illumination, which are increasing the output and reliability of the system and, therefore, the overall cost of the microscopes. The price of HCS/I equipment varies from a hundred thousand to a million dollars, depending on the specifications. Inadequate infrastructure and less funding for R&D in emerging countries will also hinder the market as installation and maintenance costs are also very high and not easily feasible for emerging economies. Adoption of HCS/I in the analysis of 3D spheroids, microtissues, and phenotypic assays, are expected to impact gene editing studies based on CRISPR-Cas9 in the future. Moreover, the growing availability of perturbagen libraries and HCS/I infrastructure within academic research centers has prompted widespread interest in HCS/I applications among academic investigators. The combination of HCS/I with chemical genetics, where small organic molecules are used to study biological systems has emerged as a powerful approach for defining protein functions and dissecting signaling pathways. The rapid growth of genome-wide RNA interference (RNAi) technology to probe gene function in mammalian cell culture systematically has popularized HCS/I systems in academic research environments.


Note: Product cover images may vary from those shown
  • Albany Molecular Research Inc. (Amri)
  • Aurelia Bioscience Ltd.
  • Axxam Spa
  • Becton, Dickinson And Co.
  • BioTek (Agilent)
  • Charles River
  • Corning Inc.
  • Creative Biolabs
  • Curiox Biosystems Inc.
  • Cytoo Sa
  • Danaher Corp.
  • De Novo Software
  • Discoverx Corp.
  • Essen Bioscience (Sartorius)
  • Fluxion Biosciences
  • Genedata Ag
  • Hudson Robotics Inc.
  • Instrument Systems
  • Logos Biosystems
  • Lumencor Inc.
  • Merck Millipore
  • Molecular Devices (Danaher)
  • Olympus Corp.
  • Perkinelmer Inc.
  • Phenovista Biosciences Llc
  • Platypus Technologies
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Thorlabs Inc.
  • Vala Sciences Inc.
  • Yokogawa Electric Corp.
Note: Product cover images may vary from those shown